Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
08/2002
08/15/2002CA2437405A1 Potassium channel openers
08/15/2002CA2437270A1 Modified keratinocyte growth factor (kgf) with reduced immunogenicity
08/15/2002CA2437265A1 Modified leptin with reduced immunogenicity
08/15/2002CA2437260A1 Oxazolyl-pyrazole derivatives as kinase inhibitors
08/15/2002CA2437248A1 Jnk inhibitor
08/15/2002CA2437215A1 Dihydropyrazolopyridine compounds and pharmaceutical use thereof
08/15/2002CA2437214A1 Modified interleukin-1 receptor antagonist (il-1ra) with reduced immunogenicity
08/15/2002CA2437087A1 Methods for the administration of amifostine and related compounds
08/15/2002CA2437085A1 Pharmaceutical formulation comprising pyrazolo[4,3-d]pyrimidines and endothelin receptor antagonists or thienopyrimidines and endothelin receptor antagonists
08/15/2002CA2436837A1 Carboxylic acid amides, the preparation thereof and their use as pharmaceutical compositions
08/15/2002CA2436738A1 Salts of pyrimidine derivatives for use against coronary heart disease and atherosclerose
08/15/2002CA2436735A1 Coumarin compounds as microtubule stabilizing agents and therapeutic uses thereof
08/15/2002CA2436470A1 Intracellular signaling molecules
08/15/2002CA2436467A1 Processes for the production of substituted 2-(2-pyridylmethyl) sulfinyl-1h-benzimidazoles
08/15/2002CA2435989A1 Pharmaceutical composition for the therapy of lower urinary tract symptoms
08/15/2002CA2435844A1 Method and composition for rejuvinating cells, tissues, organs, hair and nails
08/15/2002CA2435835A1 Uroguanylin and cyclooxygenase-2 inhibitor combinations for inhibition of intestinal cancer
08/15/2002CA2435820A1 Phenoxy substituted benzocondensed heteroaryl derivatives as thyroid receptor ligands
08/15/2002CA2435620A1 Enteric nervous system derived stem and progenitor cells and uses thereof
08/15/2002CA2432188A1 Thiazole derivatives for treating ppar related disorders
08/14/2002EP1231274A2 Modified porteinase inhibitors
08/14/2002EP1231270A1 Novel protein and dna thereof
08/14/2002EP1230930A2 Bmp-9 compositions
08/14/2002EP1230929A1 Inhibitors of cell regulatory factors and methods for preventing or reducing scarring
08/14/2002EP1230925A1 Anti-hiv compositions
08/14/2002EP1230922A1 Agents for promoting fattening of animals and method of promoting fattening
08/14/2002EP1230921A1 Combination treatment for depression
08/14/2002EP1230918A2 An aqueous enteroclysis solution for the treatment of hepatic encephalopathy
08/14/2002EP1230389A1 Antisense inhibition of pi3 kinase p55 gamma expression
08/14/2002EP1230375A1 Inhibiting gene expression with dsrna
08/14/2002EP1230367A1 19 human secreted proteins
08/14/2002EP1230271A1 Hedgehog fusion proteins and uses
08/14/2002EP1230265A2 Ctage gene family
08/14/2002EP1230264A1 Therapeutic compositions and methods for treating disease states with mutant forms of myeloid progenitor inhibitory factor-2 (mpif-2)
08/14/2002EP1230260A1 Hcv ns3 protease inhibitors
08/14/2002EP1230254A1 Antisense modulation of src-3 expression
08/14/2002EP1230250A2 Aminoalkyl glucosaminide phosphate compounds and their use as adjuvants and immunoeffectors
08/14/2002EP1230244A2 Pyrazolecarboxylic acid tricyclic derivatives, preparation and pharmaceutical compositions containing same
08/14/2002EP1230242A1 Use of 9-substituted hypoxanthine derivatives to stimulate regeneration of nervous tissue
08/14/2002EP1230241A2 Adenosine receptor antagonists and methods of making and using the same
08/14/2002EP1230236A1 Compound with growth hormone releasing properties
08/14/2002EP1230232A2 Substituted 4h-chromene and analogs as activators of caspases and inducers of apoptosis and the use thereof
08/14/2002EP1230227A1 Benzoxa-and benzothiazolyl sulfamates and their use as steroid sulfatase inhibitors
08/14/2002EP1230224A1 Substituted 5-benzyl-2,4-diaminopyrimidines
08/14/2002EP1230222A1 1-benzylpyrazoles-3-carboxylic acid tricyclic derivatives as cannabinoid receptor antagonists
08/14/2002EP1230220A1 Beta-aminoacid compounds useful for inhibiting beta-amyloid peptide release and/or its synthesis
08/14/2002EP1230218A1 Positive modulators of nicotinic receptor agonists
08/14/2002EP1230217A1 Positive modulators of nicotinic receptor agonists
08/14/2002EP1230216A1 Positive modulators of nicotinic receptor agonists
08/14/2002EP1230215A1 Pyrrole derivatives as phosphodiesterase vii inhibitors
08/14/2002EP1229942A1 Method and formula for tumor remission and suppression of cancer
08/14/2002EP1229938A2 Potentiation of prodrug efficacy
08/14/2002EP1229930A1 Compositions and methods for treatment of allergic disorders
08/14/2002EP1229919A2 A method of effecting phosphorylation in eucaryotic cells using thiamine triphosphate
08/14/2002EP1229915A1 Protease inhibitors
08/14/2002EP1229914A1 Protease inhibitors
08/14/2002EP1229912A1 Protease inhibitors
08/14/2002EP1229911A1 Protease inhibitors
08/14/2002EP1229907A1 Prevention of plaque rupture by acat inhibitors
08/14/2002EP1229905A2 Transdermal drug delivery devices comprising (r)-(z)-1- azabicyclo[2.2.1]heptan-3-one, o-[3(3-methoxyphenyl)-2-propynyl]oxime
08/14/2002EP1229903A1 A method for chemoprevention of prostate cancer
08/14/2002EP1229894A1 Cosmetic compositions containing chick pea extract and retinoids
08/14/2002EP1229795A2 Human chemokine beta-13
08/14/2002EP1189922A4 Steroid derivatives
08/14/2002EP0988038B1 (imidazol-5-yl)methyl-2-quinolinone derivatives as inhibitors of smooth muscle cell proliferation
08/14/2002EP0977582B1 Pharmaceutical combined preparations containing erythropoietin and iron preparations
08/14/2002EP0892642B1 Use in a composition of an extract of at least one labiate of the genus rosmarinarus, cultured in vitro
08/14/2002EP0807111B1 Substituted heterocyclic compounds, preparation method therefor and pharmaceutical compositions containing same
08/14/2002EP0794772B1 Medicaments for enhancing outflow of aqueous humor in treatment of glaucoma
08/14/2002EP0790974B1 Substituted 4-biarylbutyric or 5-biarylpentanoic acids and derivatives as matrix metalloprotease inhibitiors
08/14/2002EP0764443B1 Products for the treatment of cachexia associated with tumors
08/14/2002EP0724435B1 Amidino derivatives useful as nitric oxide synthase inhibitors
08/14/2002EP0722439B1 Hiv protease inhibitors
08/14/2002EP0697876B1 Xenograft thymus
08/14/2002EP0531425B1 Combination of IGF-I and TGF-beta for bone regeneration
08/14/2002DE10102722A1 Verfahren und Testsystem zum Auffinden von Nervenzell-schützenden Substanzen Method and test system for the detection of nerve cell-protective substances
08/14/2002CN1364170A Thiophene A2A receptor agaonists
08/14/2002CN1364167A Endogenous constitutively activated G protein-coupled orphan receptors
08/14/2002CN1364166A Polymorphic salt as medicine for migraine
08/14/2002CN1364156A Novel naphthalene ureas as glucose uptake enhancers
08/14/2002CN1364155A N-Cyanomethyl amides as protease inhibitors
08/14/2002CN1364089A Chronic myeloid leukemia (CML) therapy
08/14/2002CN1364087A Methods of treatment and drug screening methods
08/14/2002CN1364085A Use of phyllanthus for treating chronically inflammatory and fibrotic processes
08/14/2002CN1364084A Method of inducing cancer cell death and tumor regression
08/14/2002CN1364082A Procyanidin oligomers inhibiting matrix metalloproteinases and medicine having same effective composition
08/14/2002CN1364077A Multilayer pharmaceutical product for release in the colon
08/14/2002CN1364073A Skin care composition for mediating cell to cell communication
08/14/2002CN1363393A Process for preparing health-care compound sheep placenta extract food series
08/14/2002CN1363390A Technology for industrially preparing spirulina polynutrient and its application
08/14/2002CN1363380A Medicine for treating xerosis syndrome and its preparing process
08/14/2002CN1363345A Nano medicine for internally eliminating scrofula and its preparing process
08/14/2002CN1363344A Nano medicine 'Buxinqi' and its preparing process
08/14/2002CN1363343A Nano medicine 'Bazheng' and its preparing process
08/14/2002CN1363341A Nano medicine 'Jiuwei Qianghuo' and its preparing process
08/14/2002CN1363338A Nano medicine 'Donggui Buxue' and its preparing process
08/14/2002CN1363335A Nano medicine 'Chuan Xiong Tea' and its preparing process
08/14/2002CN1363334A Nano medicine 'Dabuyin' and its preparing process
08/14/2002CN1363332A Nano medicine 'Zixue' and its preparing process
08/14/2002CN1363331A Nano storax medicine and its preparing process
1 ... 904 905 906 907 908 909 910 911 912 913 914 915 916 917 918 919 920 921 922 923 924 ... 1564